Patented Multiplexing
Biochip Array Technology is a immunoassay testing platform allowing for the simultaneous multi-analyte testing of a panel of related tests. The technology works by combining a panel of up to 48 tests on a single Biochip with a single set of reagents, controls and calibrators. Competitive chemiluminescent immunoassays are employed for the Biochip Arrays. A light signal generated from each of the test regions on the Biochip is simultaneously detected using digital imaging technology and compared to that from a calibration curve.
Available across a wide variety of forensic matrices this revolutionary multi-analyte testing platform is designed to allow toxicologists to achieve a complete immunoassay profile in the initial screening phase. With multiple drugs of abuse biochip arrays forming part of our unrivalled toxicology test menu we can detect over 600 drugs and drug metabolites.
What is Biochip?
Available across a wide variety of matrices for forensic, clinical and workplace toxicology, this revolutionary multi-analyte testing platform is designed to allow toxicologists to achieve a complete immunoassay profile in the initial screening phase. With multiple drugs of abuse biochip arrays forming part of our unrivalled toxicology test menu we can detect over 600 drugs and drug metabolites.
Test Menu
DoA Blockbuster
DoA I+: Classic Drugs of Abuse
DoA II: Common Drugs of Abuse
DoA III: Common Drugs of Abuse
DoA IV: Prescription Drugs
DoA Ultra/DUID
DoA MultiSTAT (Whole Blood)
DoA MultiSTAT (Urine Only)
DoA MultiSTAT (Oral Fluid Only)
DoA Hair
NPS MultiSTAT
NPS I: Classic Designer Drugs
NPS II: Designer Fentanyl & Opioids
Analysers
Evidence Investigator
Evidence MultiSTAT
Evidence+
Matrices
Randox Toxicology Biochip analysers and drugs of abuse arrays are suitable for testing a variety of sample types. The nature of the prefabricated Biochip surface, secured inside a Biochip carrier, forms ideal conditions for the reaction process to take place. As the drug of abuse testing market evolves, studies have highlighted the benefits of screening in a number of matrices in order to gain a comprehensive understanding of a patient sample profile. Consolidation of multiple matrices onto one system, offers an efficient and flexible testing solution.